A Study of 2-dose Vaccination Regimen of Ad26.ZEBOV and MVA-BN-Filo in Infants
Clinical trial NCT03929757 · COMPLETED
Trial details
- NCT number
- NCT03929757
- Sponsor
- Janssen Vaccines & Prevention B.V.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-19
- Primary completion
- 2022-08-22
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.